01 aug: Mercedes CLS Shooting Brake på vej til Danmark
07 aug: Livigno uden ski…
01-08-2012 18:07:00

UPDATE: Marathon Oil Profit Falls 61% Amid Low Crude-Oil Prices

Relateret indhold

--Marathon Oil earnings down 61% for the quarter

--Marathon Oil reducing rig counts in U.S. unconventional plays

--$375 million sale of Alaska assets expected to close in 2012 despite regulatory scrutiny

(Adds analyst comments, additional details and share price, throughout.)

By Melodie Warner and Alison Sider

Marathon Oil Corp.'s (MRO) second-quarter earnings fell 61% as lower prices for crude oil and natural-gas liquids hurt its exploration-and-production earnings, prompting the company to adjust its U.S. drilling activity.

Last year, Marathon Oil spun off its downstream and petroleum assets--creating Marathon Petroleum Corp. (MPC)--as it looked to focus its drilling efforts on unconventional U.S. oil shales, such as the Bakken field in North Dakota, Anadarko Woodford in Oklahoma and Eagle Ford in Texas.

Now, facing commodity prices that are falling faster than costs, Marathon Oil is taking rigs out of those same areas. Marathon said Wednesday it will reduce its rig count in its Bakken and Anadarko Woodford sites for the remainder of 2012, and perhaps into 2013, due to lower commodity prices, especially in the inland U.S. crude-oil and natural-gas liquids markets. Natural-gas liquids include propane and butane.

"This lower-price environment, coupled with costs that have not declined at a comparable rate, dictate a more-disciplined level of domestic spending and activity," Chief Executive Clarence Cazalot Jr. said.

Several other oil companies, including ConocoPhillips (COP) and Occidental Petroleum Corp. (OXY), are facing the same problems, but have disclosed plans to increase capital spending through the end of the year.

Marathon Oil reported a second-quarter profit of $393 million, or 56 cents a share, down from $996 million, or $1.39, a year earlier. Excluding items such as gains or losses on asset sales and impairments, adjusted earnings fell to 59 cents from 96 cents. Revenue fell 2.1% to $3.78 billion.

Analysts polled by Thomson Reuters had most recently forecast earnings of 59 cents a share on revenue of $3.35 billion.

Gross margin rose to 39% from 24%.

Analysts on Wednesday said the company's earnings were solid and praised its fiscal discipline.

While Marathon Oil is raising its exploration profile internationally with several new deals in recent months, on Tuesday it said it has dropped the number of rigs to two from six in the Anadarko Woodford play as a result of low prices for natural-gas liquids and natural gas. In the Bakken field, Marathon Oil has reduced its rig count to five from eight due to volatile commodity prices.

In the Eagle Ford play, Marathon will cut back to 18 rigs from 20, but said that, with gains in efficiencies, planned growth there will remain on track.

Raymond James analyst Pavel Molchanov said he expects most U.S. oil companies will have to slow down drilling activity and cut capital expenditures next year. Raymond James is forecasting Brent crude-oil prices of $80 a barrel and West Texas Intermediate crude-oil prices of $65 a barrel in 2013.

"Insofar as Marathon is taking its foot off the accelerator now, that seems like a smart move," he said.

WTI crude oil, or light, sweet crude oil traded on the New York Mercantile Exchange, was up 64 cents, or 0.7%, at $88.67 a barrel in midday trading. Meanwhile, Brent crude oil, traded on the IntercontinentalExchange, recently was $1.11, or 1.1%, higher at $106.07.

Marathon Oil's exploration-and-production earnings dropped 44% from a year earlier.

The company Wednesday said it still expects its planned sale of $375 million in Alaska oil-and-gas assets to close by the end of the year. On Tuesday, Marathon Oil confirmed that the Federal Trade Commission has asked for more information to take a closer look at the disclosed sale to HilCorp Energy Corp.

On Tuesday, Marathon Petroleum said its second-quarter profit edged up 1.5% in its first full year as a standalone entity, as the refining-and-pipeline company booked profit gains in its Speedway and refining and marketing segments.

Marathon Oil shares were trading down 1.17% at $26.16 Wednesday morning.

Write to Melodie Warner at melodie.warner@dowjones.com and Alison Sider at alison.sider@dowjones.com.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

August 01, 2012 12:07 ET (16:07 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Vestas vinder mølleordre i USA

21-02-2018 13:57:11
Vestas har fået en ordre på 50 megawatt (MW) i USA. Ordren er på V136-3,45 MW-møllen, der er optimeret til 3,6 MW.Den mølletype har siden oktober 2017 givet Vestas en samlet ordreindgang i USA på mere end 900 MW.Det oplyser Vestas i en meddelelse.Kontrakten med kunden, der har ønsket at være anonym, omfatter levering og installation samt idriftsættelse af møllerne, og der er også en flerårig servi..

Vestas henter italiensk ordre på 57 MW - NY

21-02-2018 11:18:47
Vestas har modtaget en bestilling på vindmøller med en samlet kapacitet på 57 megawatt (MW) til et projekt i Italien.Kunden er energiselskabet E.On.Det fremgår af en meddelelse onsdag formiddag.Ordren omfatter 19 styk V112-3,0 MW-møller, og kontrakten er resultatet af et udbud over italienske vindmølleprojekter, og det såkaldte Morcone-projekt, som møllerne skal bruges til, bliver et af de største..

Aktier/tendens: Vestas, Genmab og Mærsk kan komme i fokus

21-02-2018 08:29:48
En række analyseændringer på blandt andre Mærsk, Vestas og Sydbank kan komme til at spille ind på den danske aktieåbning onsdag, hvor investorerne kan se frem til en stribe regnskaber fra nogle af de mindre banker - og efter børslukketid fra C25-selskabet Genmab.Overordnet set tyder det på en næsten uændret åbning i Europa - måske med en tendens til marginale fald efter en lettere negativ drejning..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/tendens: Vestas, Genmab og Mærsk kan komme i fokus
2
Tirsdagens aktier: Varme Vestas trak C25 i spinkelt plus
3
Genmab: Darzalex-salget i USA steg med 6,2 pct. i januar
4
Vestas vinder mølleordre i USA
5
Mærsk/Sydbank: Aktionærer kan se frem til udbetaling i 2018 eller 2019

Relaterede aktiekurser

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
21. februar 2018 16:26:38
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180219.1 - EUROWEB1 - 2018-02-21 16:26:38 - 2018-02-21 16:26:38 - 1 - Website: OKAY